Last edition
News about "Teva Pharmaceuticals"
Teva Pharmaceuticals Launches First Generic Version of Saxenda in US
The first generic version of Saxenda, Liraglutide injection, is approved for adults with obesity or overweight who have weight-related medical conditions, as well as for paediatric patients aged 12 to 17 years weighing more than 60 kg with obesity.
Teva Pharmaceuticals | 30/08/2025 | By Dineshwori | 272
Global Topical Antibiotics Market Projected to Surpass USD 11 Billion by 2032
The global topical antibiotics market, valued at USD 6.42 billion in 2024, is expected to reach nearly USD 11.20 billion by 2032.
Teva Pharmaceuticals | 14/07/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy